Q2L-22080-04331
4 vaccinations
2 coded responses
45 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 984 / WA
- Registered
- 2021-12-17
- Relationship
- Child or adolescent in my care
- Guardian
- CTG-85676-91481
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-17
Registered in v-safe
-
2021-12-17
Dose 1 — Pfizer-BioNTech
- 2021-12-17
-
2021-12-18
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Dizziness, Head discomfort, Paranasal sinus discomfort — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Head/sinus pressure; very mild dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Itching · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-20
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-12-21
-
2021-12-22
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-12-23
- 2021-12-25
- 2022-01-01
-
2022-01-07
Dose 2 — Pfizer-BioNTech
- 2022-01-07
-
2022-01-08
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain, Itching · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2022-01-09
-
2022-01-10
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-11
- 2022-01-12
- 2022-01-13
- 2022-01-16
- 2022-01-21
- 2022-01-30
- 2022-02-08
- 2022-02-13
- 2022-02-20
- 2022-04-08
-
2022-06-22
Dose 3 — Pfizer-BioNTech
- 2022-06-22
-
2022-06-23
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2022-06-24
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-06-25
- 2022-06-26
-
2022-06-29
Survey response — day 7, dose 3, dependentMedDRA: Decreased appetite — Feeling: GoodFree text: Decreased appetiteMedDRA releases: 2024-11 · check-in free text available
- 2022-07-07
- 2022-07-15
- 2022-07-27
- 2022-08-03
- 2022-09-21
-
2022-11-23
Dose 4 — Pfizer-BioNTech
- 2022-11-23
-
2022-11-25
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Itching · HeadacheAdult check-in
- 2022-11-26
- 2022-11-29
- 2022-11-30
- 2022-12-08
- 2022-12-14
- 2022-12-23
- 2023-01-06
- 2023-02-24
- 2023-05-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-17 | Pfizer-BioNTech | No |
| 2 | 2022-01-07 | Pfizer-BioNTech | No |
| 3 | 2022-06-22 | Pfizer-BioNTech | No |
| 4 | 2022-11-23 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Head/sinus pressure; very mild dizziness
Release 12 — day 7, dose 3, dependent
Systemic reaction (other): Decreased appetite
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Head discomfort | · | · | ✓ |
| SRO | Paranasal sinus discomfort | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release